Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Daniel N. Prater"'
Autor:
Nagajyothi Nalluri, Daniel N. Prater, Sashwati Roy, Ravichand Palakurti, Natalia Higuita-Castro, Chandan K. Sen, Andrew G. Clark, Subhadip Ghatak, Richard Stewart, Daniel Gallego-Perez, Savita Khanna
Publikováno v:
Nanomedicine
This work rests on our recent report on the successful use of tissue nanotransfection (TNT) delivery of Ascl1, Brn2, and Myt1l (TNT(ABM)) to directly convert skin fibroblasts into electrophysiologically active induced neuronal cells (iN) in vivo. Her
Autor:
Alyssa C. Leapley, W. Chris Shelley, Mervin C. Yoder, Daniel N. Prater, Paul J. Critser, Lan Huang, Alice F. Tarantal, Pingyu Zeng, David A. Ingram
Publikováno v:
Pediatric Research. 71:156-161
We have identified a novel hierarchy of human endothelial colony-forming cells (ECFCs) that are functionally defined by their proliferative and clonogenic potential and in vivo vessel-forming ability. The rhesus monkey provides an excellent model in
Autor:
Charles C. Lee, Simon R. Cherry, Cynthia A. Batchelder, Jared E. Christensen, Alice F. Tarantal, Daniel N. Prater
Publikováno v:
Molecular Imaging and Biology. 14:197-204
The goals of this study were to optimize radiolabeling of renal lineages differentiated from human embryonic stem (hES) cells and use noninvasive imaging (positron emission tomography (PET) and bioluminescence imaging (BLI)) to detect the cells in fe
Publikováno v:
Journal of Perinatology. 30:724-730
Endothelial progenitor cells (EPCs) have been examined in numerous adult diseases and have been suggested as a cellular-based therapy. However, there are no reports describing EPCs being isolated from newborn peripheral blood. Endothelial colony-form
Autor:
Stephanie Merfeld-Clauss, Dmitry O. Traktuev, Keith L. March, Daniel N. Prater, Michael P. Murphy, David A. Ingram, Aravind Sanjeevaiah, Brian Johnstone, M. Reza Saadatzadeh
Publikováno v:
Circulation Research. 104:1410-1420
Rapid induction and maintenance of blood flow through new vascular networks is essential for successfully treating ischemic tissues and maintaining function of engineered neo-organs. We have previously shown that human endothelial progenitor cells (E
Autor:
Jalees Rehman, Daniel N. Prater, M. Reza Saadatzadeh, Michael P. Murphy, David A. Ingram, Yanmin Zhang, Laura E. Mead
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 296:H1675-H1682
Cell therapy with endothelial progenitor cells (EPCs) is an emerging therapeutic option to promote angiogenesis or endothelial repair. Although the release of angiogenic paracrine factors is known to contribute to their therapeutic effect, little is
Publikováno v:
Leukemia. 21:1141-1149
Since 1997, postnatal vasculogenesis has been purported to be an important mechanism for neoangiogenesis via bone marrow (BM)-derived circulating endothelial progenitor cells (EPCs). Based on this paradigm, EPCs have been extensively studied as bioma
Autor:
Daniel N. Prater, John J. Rusek
Publikováno v:
Applied Energy. 74:135-140
At present, the use of hydrogen and oxygen gases is necessary to achieve a reasonable power density in fuel-cell systems. However, the overall energy density of a hydrogen/oxygen fuel cell system is low in comparison with many present, or alternate,
Publikováno v:
Current Protocols in Stem Cell Biology
Circulating endothelial progenitor cells (EPCs) in adult human peripheral blood were originally identified in 1997 by Asahara et al., which challenged the paradigm that vasculogenesis is a process restricted to embryonic development. Since their orig
Autor:
Mervin C. Yoder, Sheeny K. Lan, Daniel N. Prater, David A. Ingram, Russell D. Jamison, Amy J. Wagoner Johnson
Publikováno v:
ASME 2008 Summer Bioengineering Conference, Parts A and B.
The natural healing process cannot restore form and function to critical size bone defects without the presence of a graft to support and guide tissue regeneration [1]. Critical size bone defects in humans are typically on the order of centimeters or